Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer

BACKGROUND: We previously reported the clinical efficacy of adoptive immunotherapy (AIT) with dendritic cells (DCs) pulsed with mucin 1 (MUC1) peptide and cytotoxic T lymphocytes (CTLs). We also reported that gemcitabine (GEM) enhances anti-tumor immunity by suppressing regulatory T cells. Therefore...

詳細記述

保存先:
書誌詳細
主要な著者: Shindo, Yoshitaro, Hazama, Shoichi, Maeda, Yoshinari, Matsui, Hiroto, Iida, Michihisa, Suzuki, Nobuaki, Yoshimura, Kiyoshi, Ueno, Tomio, Yoshino, Shigefumi, Sakai, Kohei, Suehiro, Yutaka, Yamasaki, Takahiro, Hinoda, Yuji, Oka, Masaaki
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2014
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4074851/
https://ncbi.nlm.nih.gov/pubmed/24947606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-175
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料